Study shows PromarkerD ability to also predict late-stage kidney decline in type-2 diabetes patients
The Company is pleased to announce the results of a study demonstrating the potential ability of...
Related posts
Proteomics International Laboratories soared 13 per cent after its shares came out of voluntary...
Study shows PromarkerD is significantly better than current standard of care tests eGFR and ACR for...